Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive
1 clinical trials · Condition
◉ Watch Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive
| Record | Firm | Date |
|---|---|---|
| OPALINE : A Study Of Morbidity And Mortality At 2 Years (NCT02264665) | Pfizer | 2015-05-12 |
Track Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive automatically
Every clearance here is in the API, with alerts when new ones post.